<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Physiology and Pharmacology</title>
<title_fa></title_fa>
<short_title>Physiol Pharmacol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ppj.phypha.ir</web_url>
<journal_hbi_system_id>32</journal_hbi_system_id>
<journal_hbi_system_user>journal32</journal_hbi_system_user>
<journal_id_issn>24765236</journal_id_issn>
<journal_id_issn_online>24765244</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.22034</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>(previous ISSN: 17350581)</journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1384</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2005</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>9</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa>A2C8 and MC2B8 Monoclonal Antibodies Against Human Plasminogen inhibit
Fibrinolytic System</title_fa>
	<title></title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa>Experimental research article</content_type_fa>
	<content_type>Experimental research article</content_type>
	<abstract_fa>&lt;b&gt;&lt;font face=&quot;TimesNewRomanPS-BoldMT&quot; size=&quot;2&quot;&gt;&lt;p align=&quot;left&quot;&gt;A Maleki&lt;/p&gt;&lt;/font&gt;&lt;font face=&quot;TimesNewRomanPS-BoldMT&quot; size=&quot;1&quot;&gt;1&lt;/font&gt;&lt;font face=&quot;TimesNewRomanPS-BoldMT&quot; size=&quot;2&quot;&gt;, M Mirshahi&lt;/font&gt;&lt;font face=&quot;TimesNewRomanPS-BoldMT&quot; size=&quot;1&quot;&gt;2&lt;/font&gt;&lt;font face=&quot;TimesNewRomanPS-BoldMT&quot; size=&quot;2&quot;&gt;, AA Pourfathollah&lt;/font&gt;&lt;font face=&quot;TimesNewRomanPS-BoldMT&quot; size=&quot;1&quot;&gt;1 &lt;/font&gt;&lt;font face=&quot;TimesNewRomanPS-BoldMT&quot; size=&quot;2&quot;&gt;and K Mansouri&lt;/font&gt;&lt;font face=&quot;TimesNewRomanPS-BoldMT&quot; size=&quot;1&quot;&gt;1&lt;/font&gt;&lt;i&gt;&lt;font face=&quot;TimesNewRomanPS-BoldItalicMT&quot; size=&quot;2&quot;&gt;&lt;p align=&quot;left&quot;&gt;1. Dep. Hematology, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;2. Dep. Biochemistry, School of Basic Sciences, Tarbiat Modares University, Tehran, Iran.&lt;/p&gt;&lt;/font&gt;&lt;font face=&quot;TimesNewRomanPS-BoldMT&quot; size=&quot;3&quot;&gt;&lt;p align=&quot;left&quot;&gt;Abstract:&lt;/p&gt;&lt;/font&gt;&lt;font face=&quot;TimesNewRomanPSMT&quot; size=&quot;3&quot;&gt;&lt;p align=&quot;left&quot;&gt;In the present study the effects of two antiplasminogen monoclonal antibodies A2C8 and MC2B8 on the activation&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;of the fibrinolytic system was studied.&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;For this purpose, after separate steps like the culture of antibody producing hybridoma cells, their injection to&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;mice, and purification of antibodies from ascites fluid, the effects of these antibodies was studied with various&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;methods. Primary observation with pooled plasma showed that these antibodies in the presence of plasminogen&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;activators (t-PA, u-PA and SK) can inhibit the activation of fibrinolytic system. According the results obtained&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;from D-dimer assay, the inhibition effects of these antibodies is dose dependent. The other test that performed&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;with S-2251 synthetic substrate showed that the activation of plasminogen in the presence of Urokinase and in the&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;result, deterioration of this substrate was decreased in the presence of A2C8 and MC2B8 antibodies.&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;In the present study we evaluated the effects and mechanism of two antiplasminogen monoclonal antibodies A2C8&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;and MC2B8 on the activation of the fibrinolytic system in the presence of plasminogen activators.&lt;/p&gt;&lt;/font&gt;&lt;b&gt;&lt;font face=&quot;TimesNewRomanPS-BoldMT&quot; size=&quot;3&quot;&gt;&lt;p align=&quot;left&quot;&gt;Keywords: &lt;/p&gt;&lt;/font&gt;&lt;font face=&quot;TimesNewRomanPSMT&quot; size=&quot;3&quot;&gt;Fibrinolytic system, Plasminogen, Monoclonal antibody, Plasminogen activators.&lt;/font&gt;&lt;/b&gt;&lt;/i&gt;&lt;/b&gt;</abstract_fa>
	<abstract></abstract>
	<keyword_fa></keyword_fa>
	<keyword></keyword>
	<start_page>203</start_page>
	<end_page>209</end_page>
	<web_url>http://ppj.phypha.ir/browse.php?a_code=A-10-57-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
</author_list>


	</article>
</articleset>
</journal>
